BLUE
bluebird bio
BLUE
BLUE
Delisted
BLUE was delisted on the 30th of May, 2025.
229 hedge funds and large institutions have $1.59B invested in bluebird bio in 2021 Q1 according to their latest regulatory filings, with 48 funds opening new positions, 85 increasing their positions, 64 reducing their positions, and 78 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
42% less capital invested
Capital invested by funds: $2.73B → $1.59B (-$1.14B)
44% less call options, than puts
Call options by funds: $25.8M | Put options by funds: $45.8M
Holders
229
Holding in Top 10
1
Calls
$25.8M
Puts
$45.8M
Top Buyers
| 1 | +$47.3M | |
| 2 | +$32.7M | |
| 3 | +$26.4M | |
| 4 |
SC
Sessa Capital
New York
|
+$26.4M |
| 5 |
CS
Credit Suisse
Zurich,
Switzerland
|
+$24.5M |
Top Sellers
| 1 | -$352M | |
| 2 | -$137M | |
| 3 | -$135M | |
| 4 |
Capital International Investors
Los Angeles,
California
|
-$48.8M |
| 5 |
CC
Casdin Capital
New York
|
-$39.6M |